首页> 外文期刊>European journal of cancer care >Usefulness of oral corticosteroid in Rosai-Dorfman disease.
【24h】

Usefulness of oral corticosteroid in Rosai-Dorfman disease.

机译:口服皮质类固醇激素在罗莎-多夫曼病中的作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Rosai-Dorfman disease (RDD), also known as sinus histiocytosis with massive lymphadenopathy, is a benign self-limiting disorder of unknown aetiology, which is frequently mistaken for lymphoma. There is no consensus as to the proper management of this disorder. In the past, potentially harmful treatments, such as antineoplastic drugs, have been advocated. We describe a 25-year-old woman with RDD who has had a remarkably favourable response to oral prednisolone therapy. Our observation strengthens the conclusions of previous case reports as to the effectiveness of corticosteroids in this condition. This article is aimed at creating awareness among clinical oncologists about this pseudolymphomatous disorder and emphasizing the therapeutic role of corticosteroids.
机译:Rosai-Dorfman病(RDD),也称为窦性组织细胞增生症伴大量淋巴结肿大,是一种病因不明的良性自限性疾病,经常被误认为是淋巴瘤。对于这种疾病的正确治疗尚无共识。过去,已经提倡使用可能有害的治疗方法,例如抗肿瘤药。我们描述了一名25岁的RDD妇女,她对口服泼尼松龙的治疗反应非常好。我们的观察结果加强了先前病例报告中有关糖皮质激素在这种情况下的有效性的结论。本文旨在提高临床肿瘤学家对这种假淋巴瘤疾病的认识,并强调皮质类固醇的治疗作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号